Bollard Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-680
| Closed | -$13K | – | 321 |
|
|
2022
Q1 | $13K | Hold |
680
| – | – | ﹤0.01% | 398 |
|
|
2021
Q4 | $18K | Hold |
680
| – | – | ﹤0.01% | 395 |
|
|
2021
Q3 | $28K | Hold |
680
| – | – | ﹤0.01% | 377 |
|
|
2021
Q2 | $39K | Hold |
680
| – | – | ﹤0.01% | 361 |
|
|
2021
Q1 | $29K | Hold |
680
| – | – | ﹤0.01% | 378 |
|
|
2020
Q4 | $48K | Hold |
680
| – | – | ﹤0.01% | 340 |
|
|
2020
Q3 | $19K | Hold |
680
| – | – | ﹤0.01% | 388 |
|
|
2020
Q2 | $20K | Buy |
+680
| New | +$20K | ﹤0.01% | 411 |
|